tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Umer Raffat, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).
Analyst Umer Raffat, currently employed at EVERCORE, carries an average stock price target met ratio of 37.5% that have a potential upside of 11.22% achieved within 154 days.
Umer Raffat’s has documented 24 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALKS, Alkermes Plc at 23-Oct-2023.
Analyst best performing recommendations are on JAZZ (JAZZ PHARMACEUTICALS PLC).
The best stock recommendation documented was for JAZZ (JAZZ PHARMACEUTICALS PLC) at 2/22/2017. The price target of $160 was fulfilled within 64 days with a profit of $25.05 (18.56%) receiving and performance score of 2.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$18
$8.72 (93.97%)
$24
5 months 4 days ago
(14-May-2025)
1/6 (16.67%)
$9.25 (105.71%)
278
Hold
$10
$0.72 (7.76%)
$15
5 months 14 days ago
(04-May-2025)
5/11 (45.45%)
$1.32 (15.21%)
100
Buy
$24
$14.72 (158.62%)
$28
8 months 5 days ago
(13-Feb-2025)
0/2 (0%)
$9.06 (60.64%)
Sell
$20
$10.72 (115.52%)
$38
1 years 1 months 13 days ago
(05-Sep-2024)
1/2 (50%)
$0.32 (1.63%)
10
Hold
$20
$10.72 (115.52%)
$18
1 years 5 months 13 days ago
(05-May-2024)
3/4 (75%)
$0.68 (3.52%)
62
What Year was the first public recommendation made by Umer Raffat?
